Cancer Resource Center

Cancer is a complex and heterogeneous disease arising from the disruption of normal cellular functions through genetic or epigenetic changes. To better understand the mechanisms driving cancer, researchers can examine the key traits acquired by all cancer cells that enable them to grow, survive, and spread, as described by Hanahan and Weinberg in The Hallmarks of Cancer.

With decades of scientific expertise in building innovative assay tools for cancer research, CST offers a range of kits and reagents you can trust to drive innovative cancer breakthroughs, no matter which cancer hallmark you’re investigating. Whether you’re focused on basic cancer research or targeting an underlying cause behind cancer pathogenesis, CST offers products to support your workflow from start to finish.

Use the menu on the right to explore how CST can guide you through your cancer research project planning, assay design, and beyond.

Learn Biological Processes

Browse these educational resources from CST to find out more about the key characteristics driving cancer progression, as they align with The Hallmarks of Cancer.

Experimental Design & Assay Enablement

Antibody-based tools power your cancer research. Whether you are visualizing protein localization, analyzing DNA-protein interactions, or determining protein quantification, CST offers a wide range of products and resources to build your next assay.

Looking for CST solutions based on a specific cancer hallmark? Visit the Interrogate the Hallmarks of Cancer page for examples of antibodies, kits, and assays that will help you answer commonly asked questions for each hallmark.

Characterize Cells and Tissue

When investigating a specific cancer hallmark, it is essential to study a relevant cell type or model system in an appropriate physiological state; otherwise, your findings may be unreliable. For instance, cells should not be undergoing cell death when examining markers for proliferative growth. Moreover, when focusing on specific cellular processes, it is often crucial to consider the subcellular localization of the proteins involved.

CST provides highly specific, validated antibodies against key markers, enabling you to characterize cells and tissues with confidence.

Refer to the Cancer Biomarkers Guide for Immunohistochemistry to find highly specific, rigorously validated antibodies against a wide variety of biomarkers for specific cancer types to help you examine cancer development and progression.

Discover

Use this curated collection of pathways, diagrams, and products relevant to key cancer hallmarks to help you examine the cellular mechanisms driving cancer. The meticulously researched and designed pathway diagrams represent evidence-based signaling information, helping you find the best products to fuel your research.

Translate

Leverage the expertise of CST scientists to streamline your discovery and accelerate cancer therapeutic development. Our comprehensive portfolio to support cancer research includes recombinant monoclonal antibodies, ELISA and cellular assay kits, custom products, and services.

Solutions for Oncology Therapeutics Discovery

CAR-Engineered Cell Characterization Solutions

Solutions for Drug Discovery and Development

Solutions for Antibody Pair-Based Immunoassay Development